Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.1M Sell
21,140
-656
-3% -$119K 0.21% 111
2026
Q1
$3.77M Sell
21,796
-3,216
-13% -$523K 0.29% 79
2025
Q4
$4.88M Sell
25,012
-2,985
-11% -$711K 0.42% 51
2025
Q3
$7.87M Buy
27,997
+3,058
+12% +$779K 0.71% 27
2025
Q2
$5.45M Sell
24,939
-3,151
-11% -$509K 0.55% 37
2025
Q1
$3.93M Sell
28,090
-977
-3% -$159K 0.43% 50
2024
Q4
$4.84M Buy
29,067
+2,445
+9% +$434K 0.52% 39
2024
Q3
$4.54M Sell
26,622
-1,259
-5% -$182K 0.59% 42
2024
Q2
$3.94M Buy
27,881
+543
+2% +$67.4K 0.53% 46
2024
Q1
$3.43M Buy
27,338
+2,218
+9% +$254K 0.47% 55
2023
Q4
$2.65M Sell
25,120
-4,451
-15% -$486K 0.41% 69
2023
Q3
$3.13M Buy
29,571
+434
+1% +$50.2K 0.47% 62
2023
Q2
$3.47M Buy
29,137
+31
+0.1% +$3.21K 0.51% 60
2023
Q1
$2.7M Buy
+29,106
New +$2.55M 0.42% 64

Other funds holding ORCL

Nilsine Partners's ORCL Position: Q2 2026 in Review

Nilsine Partners reduced its Oracle (ORCL) stake by 3% in Q2 2026, selling an estimated $119K and leaving 21,140 shares worth $3.1M. The position accounts for 0.21% of the portfolio, ranked #111.

Nilsine Partners first reported a position in ORCL in Q1 2023 and has held it in 14 quarters since. The position peaked at $7.87M in Q3 2025. 1,158 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Nilsine Partners held 21,140 shares of Oracle worth $3.1M as of Q2 2026.
  • Nilsine Partners sold 656 Oracle shares in Q2 2026, an estimated $119K.
  • Oracle made up 0.21% of Nilsine Partners's portfolio in Q2 2026, its #111 holding.
  • Nilsine Partners first reported a position in Oracle in Q1 2023 and has held it in 14 quarters since.
  • Nilsine Partners's Oracle position peaked at $7.87M in Q3 2025.
  • 1,158 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Nilsine Partners's 13F filing for Q2 2026, filed 24 Jul 2026.